Overview
The purpose of this study is to evaluate if TCD601 can induce allogeneic tolerance in de novo living donor renal transplant recipients
Eligibility
Key Inclusion Criteria:
- Able to understand the study requirements and provide written informed consent before and study assessment is performed.
- Male or female patients ≥ 18 to 60 years of age.
- Recipient of a first renal transplant from a non-HLA identical, but at least haploidentical, ABO compatible living donor.
Key Exclusion Criteria:
- Women of child-bearing potential
- Subjects with a history of cancer
- Donor-specific antibody